Equity Profile

RVTY

Revvity, Inc.

Health CareLife Sciences Tools & Services$11.7B

May5Tue

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:00 AM EDT

Revvity, Inc. Beats on EPS, Stock Up 6.69%

Metric	Actual	Expected	Surprise
EPS	$1.04	$1.02	+2.16%
Revenue	—	$704M	—

management commentary, guidance changes, and full analysis available with Pro.

Revvity, Inc. Beats on EPS, Stock Up 6.69%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$1.04	$1.02	+2.16%
Revenue	—	$704M	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

Revvity, Inc. reported better-than-expected earnings per share, which likely contributed to a positive stock reaction, with shares rising by 6.69%. However, there was no revenue reported, leaving some uncertainty about overall performance. Investors may be encouraged by the EPS beat, but the lack of revenue data could raise questions about future growth prospects.

Company Snapshot

Revvity, Inc. operates in the health care sector, focusing on life sciences tools and services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$1.02

Revenue

Total revenue reflects the company's ability to generate sales and is essential for assessing growth.

$704M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Revvity, Inc. operates in the health care sector, focusing on life sciences tools and services. The company plays a crucial role in advancing research and development in the life sciences, which is vital for improving health outcomes and driving innovation in medical technologies.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q4-2025, Revvity reported an EPS of $1.70, exceeding estimates by 7.26%. However, the stock experienced a decline of 1.57% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Revvity to report solid earnings this quarter, with a consensus EPS of $1.02 and revenue of $704 million. The market is keenly watching for any surprises.

Bull Case

If Revvity exceeds EPS expectations and shows strong revenue growth, it could signal robust demand for its products and services, potentially boosting investor confidence.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it could raise concerns about its growth prospects and negatively impact the stock.

Key Metrics to Watch

EPS

$1.02

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$704M

Total revenue reflects the company's ability to generate sales and is essential for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Revvity's EPS exceed the consensus estimate of $1.02?

A beat on EPS would reinforce the company's growth narrative and could positively influence stock performance.

What guidance will Revvity provide regarding future revenue growth?

Guidance on revenue growth is crucial for understanding the company's outlook and could impact investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Revvity's potential for revenue growth due to its strong product pipeline and market demand.

Supporting Evidence

The company's recent earnings history shows consistent EPS beats, indicating stronger-than-expected performance.

Options pricing suggests a significant move, which may reflect underlying confidence not captured in consensus estimates.

Key Risk

If Revvity's revenue growth significantly outpaces expectations, it could challenge the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Revvity can maintain its growth trajectory amidst market challenges.

Bull Confirmed If

An EPS of $1.03 or higher, coupled with revenue exceeding $710M, would confirm the bull case.

Bear Confirmed If

An EPS below $1.00 or revenue below $693M would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±13.1%

Historical Avg

±3.6%

Pricing rich

The options market is pricing in a significant move around the earnings report, indicating heightened uncertainty or anticipation.

Options are pricing a 13.1% move, while the stock has averaged only 3.6% in historical moves, suggesting a rich setup.

Detail

ATM IV

0.7%

30d HV

41.2%

Calls (78K)P/C Ratio: 1.36Puts (106K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias).

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$7,424.00

80 sh

1 insider

Net

$7,424.00

Net selling

Most Active Insiders· 1 open-market trade

Vice President and CAOGonzales Anita
$7,424.00
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations, history suggests a potential average one-day move of +0.53%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with historical data indicating an average one-day move of -0.82% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market demand and competitive positioning.
3Details on cost management strategies and their effect on margins.
4Insights into customer acquisition and retention metrics.
5Guidance on future revenue expectations and any potential challenges.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Revvity, Inc. operates in the health care sector, focusing on life sciences tools and services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$1.02

Revenue

Total revenue reflects the company's ability to generate sales and is essential for assessing growth.

$704M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q4-2025, Revvity reported an EPS of $1.70, exceeding estimates by 7.26%. However, the stock experienced a decline of 1.57% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Revvity to report solid earnings this quarter, with a consensus EPS of $1.02 and revenue of $704 million. The market is keenly watching for any surprises.

Bull Case

If Revvity exceeds EPS expectations and shows strong revenue growth, it could signal robust demand for its products and services, potentially boosting investor confidence.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it could raise concerns about its growth prospects and negatively impact the stock.

Key Metrics to Watch

EPS

$1.02

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$704M

Total revenue reflects the company's ability to generate sales and is essential for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Revvity's EPS exceed the consensus estimate of $1.02?

A beat on EPS would reinforce the company's growth narrative and could positively influence stock performance.

What guidance will Revvity provide regarding future revenue growth?

Guidance on revenue growth is crucial for understanding the company's outlook and could impact investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Revvity's potential for revenue growth due to its strong product pipeline and market demand.

Supporting Evidence

The company's recent earnings history shows consistent EPS beats, indicating stronger-than-expected performance.

Options pricing suggests a significant move, which may reflect underlying confidence not captured in consensus estimates.

Key Risk

If Revvity's revenue growth significantly outpaces expectations, it could challenge the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Revvity can maintain its growth trajectory amidst market challenges.

Bull Confirmed If

An EPS of $1.03 or higher, coupled with revenue exceeding $710M, would confirm the bull case.

Bear Confirmed If

An EPS below $1.00 or revenue below $693M would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±13.1%

Historical Avg

±3.6%

Pricing rich

The options market is pricing in a significant move around the earnings report, indicating heightened uncertainty or anticipation.

Options are pricing a 13.1% move, while the stock has averaged only 3.6% in historical moves, suggesting a rich setup.

Detail

ATM IV

0.7%

30d HV

41.2%

Calls (78K)P/C Ratio: 1.36Puts (106K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias).

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$7,424.00

80 sh

1 insider

Net

$7,424.00

Net selling

Most Active Insiders· 1 open-market trade

Vice President and CAOGonzales Anita
$7,424.00
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations, history suggests a potential average one-day move of +0.53%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with historical data indicating an average one-day move of -0.82% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market demand and competitive positioning.
3Details on cost management strategies and their effect on margins.
4Insights into customer acquisition and retention metrics.
5Guidance on future revenue expectations and any potential challenges.